Fisher Asset Management’s CareDx CDNA Stock Holding History

Fisher Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-112,270	Closed	-$2.54M	–	830
2019 Q3	$2.54M	Buy	+112,270	New	+$3.11M	﹤0.01%	509

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Fisher Asset Management's CDNA Position: Q4 2019 in Review

Fisher Asset Management sold out of CareDx (CDNA) in Q4 2019, closing a stake of 112,270 shares — an estimated $2.54M sold.

Fisher Asset Management first reported a position in CDNA in Q3 2019 and held it in 1 quarter. The position peaked at $2.54M in Q3 2019. 159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.

Fisher Asset Management reported no remaining CareDx position as of Q4 2019 after selling out during the quarter.
Fisher Asset Management sold 112,270 CareDx shares in Q4 2019, an estimated $2.54M.
Fisher Asset Management first reported a position in CareDx in Q3 2019 and held it in 1 quarter.
Fisher Asset Management's CareDx position peaked at $2.54M in Q3 2019.
159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.

Based on Fisher Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.